Xarelto News
Most Popular Xarelto Story
FDA asks for more data on Xarelto
The FDA issued a complete response letter for Bayer and Johnson & Johnson's potential blockbuster anti-clotting drug Xarelto (rivaroxaban). The agency declined to approved the drug, requesting... Read more...
Latest Headlines
- November 19, 2009
- May 28, 2009
- May 21, 2009
- March 20, 2009
- March 17, 2009
- November 10, 2008
- September 16, 2008
- July 25, 2008
- July 25, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
